If it wasn’t clear before COVID-19, it is now: ubiquitous, worldwide testing for infectious diseases is crucial for public health and prosperity. Nucleic acid amplification tests (NAATs) are the gold standard for infectious disease diagnosis. Unfortunately, NAATs are...
Any developer of a sample-to-answer device knows that getting sample prep working on-cartridge is a major source of risk. It makes matters worse that issues with sample prep usually arise late in the development process. Sample prep is often responsible when product...
Ready or not, states are moving ahead to re-open and workers are returning to their places of employment. Understandably, many American workers are concerned about personal safety and what it means to get back into the workplace and be alongside their co-workers. ...
The first SARS-CoV-2 sequence was released on January 10, just 40 days after the incidence of pneumonia started to rise in Wuhan, China. The World Health Organization released its first diagnostic testing guidelines just one week later, on January 17. By any measure,...
Across the life sciences, the pressure to achieve faster results, and reduce costs, is driving a transition to sample-to-answer platforms. Molecular diagnostics are moving from industrial liquid handling systems to point-of-care devices. The next generation of...
At Redbud, we have a tradition of hosting an all-hands meeting every three months. We review our goals for the year, track our progress, and lay out everyone’s responsibilities for the coming quarter. We held this meeting last Wednesday, and for the first time, it was...
MXR: Magnetic micro-posts for microfluidic systems
MXR: microfluidic mixer
Cell stirring
This website uses cookies to recognize repeat user visits and preferences, analyze traffic, measure campaign effectiveness, and improve user experience. By clicking “Accept” on this banner, or using our site, you consent to the use of cookies. Learn more about our cookies in our Privacy Policy.
AcceptPrivacy policy